Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations

ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Katiane R. Servelhere, Ingrid Faber, Alberto Martinez, Renato Nickel, Adriana Moro, Francisco M. B. Germiniani, Mariana Moscovich, Tatiane R. Blume, Renato P. Munhoz, Hélio A. G. Teive, Marcondes C. França Jr
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Thieme Revinter Publicações
Rangatū:	Arquivos de Neuro-Psiquiatria
Ngā marau:	toxinas botulínicas paraparesia espástica hereditária espasticidade muscular
Urunga tuihono:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300183&lng=en&tlng=en
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!